image

On-Demand Programs

Since 2011, Encore Medical Education has pioneered independent medical education worldwide. We are recognized for our strong alliances with key opinion leaders, specialty associations, and leading institutions. Encore designs and delivers impactful clinician education programs in Europe, Latin America, Asia, the Middle East, and the United States. We offer meticulously tailored programs that set the gold standard to improve clinical care and patient outcomes. 

Transforming Obesity Management Globally – Clinical Perspectives

This CME activity equips primary care providers and relevant specialists with the knowledge and skills to address obesity as a chronic, relapsing disease. Participants explored the pathophysiology of obesity and its cardiovascular, renal, and metabolic complications, alongside strategies for accurate diagnosis, nonstigmatizing patient communication, and evidence-based management—including nutrition counseling, behavioral therapy, pharmacotherapy, and bariatric surgery. The Obesity Society designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™.

CLICK TO LEARN MORE

Transforming Obesity Management Globally – Expert Roundtable

Obesity has reached epidemic proportions globally, yet healthcare professionals often lack the training and interdisciplinary support needed to effectively manage it across diverse patient populations. Following ObesityWeek® 2025, an international expert roundtable addressed the state of obesity worldwide, covering its complex pathophysiology, culturally competent and patient-centered care strategies, and the evolving therapeutic landscape. The Obesity Society designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™.

CLICK TO LEARN MORE

Best of SABCS - USA On-Demand 2025

On-demand access to the San Francisco Best of SABCS program, directed by renowned breast cancer expert Hope Rugo, MD. The program shares the most significant and practice-changing scientific findings and insights from the annual San Antonio Breast Cancer Symposium, providing valuable updates for oncology professionals and healthcare providers worldwide.

CLICK TO LEARN MORE

Best of SABCS - Video Highlights 2025

Global breast cancer experts provide insightful commentary with original presentation slides on the most impactful general and educational sessions from the 2025 San Antonio Breast Cancer Symposium. Highlights include key results from major trials such as lidERA, HER2CLIMB-05, EMBER-3, SERENA-6, DESTINY-Breast09, evERA, and ASCENT-04, offering valuable clinical updates.

CLICK TO LEARN MORE

Revolución Course 2025

This six-module program, organized  with  the Emory Diabetes Education & Training Academy, will enhance clinical decision-making in type 2 diabetes care. It focuses on optimizing metabolic and glycemic outcomes through innovative therapies, particularly those targeting GIP and GLP-1 receptors. Participants learn to apply recent clinical data to identify patients who may benefit from these treatments. Originally produced in Spanish language.

CLICK TO LEARN MORE

Revolução Course 2025

This six-module program, organized with the Emory Diabetes Education & Training Academy, will enhance clinical decision-making in type 2 diabetes care. It focuses on optimizing metabolic and glycemic outcomes through innovative therapies, particularly those targeting GIP and GLP-1 receptors. Participants learn to apply recent clinical data to identify patients who may benefit from these treatments. Originally produced in Spanish with Portuguese subtitles.

CLICK TO LEARN MORE

Credo - 2026

Tras el éxito de sus ediciones anteriores, CReDO continúa avanzando hacia su consolidación como referente nacional, reforzando su posicionamiento como evento de excelencia científica en nuestro país. En 2026, CReDO refuerza su compromiso con el abordaje integral de la diabetes, ampliando los contenidos sobre tecnologías aplicadas a la práctica clínica y dando continuidad a áreas relevantes como la obesidad, la enfermedad hepática asociada a la disfunción metabólica (MASLD) y las complicaciones cardiorrenales. Este año, además, contamos con la colaboración de la Sociedad Portuguesa de Diabetes (SPD), lo que aporta una dimensión internacional adicional y enriquece el intercambio científico. CReDO ofrece un entorno de alto valor estratégico y reputacional, alineado con los estándares más exigentes de excelencia y calidad educativa.

Vuestra confianza ha sido clave para hacer realidad este proyecto, y esperamos continuar construyendo juntos un futuro mejor para nuestros pacientes. Un abrazo y nos vemos en Madrid.

CLICK TO LEARN MORE